IGTI11 units continue to trade normally on the B3. What happened was that Iguatemi S.A. released its third-quarter 2026 earnings on November 10, reporting an adjusted net profit of R$ 438.2 million. While the headline figure is impressive, R$ 353.5 million came from an extraordinary gain on the sale of five shopping malls; core operations told a different story.
What Happened to IGTI11?
IGTI11 units were not delisted, did not change their name, and remain actively traded on the exchange. What happened was the November 10, 2026 release of the third-quarter 2026 (Q3 2026) earnings report. Iguatemi S.A. — one of Brazil's largest shopping mall operators — reported an adjusted net profit of R$ 438.2 million for the period, marking a sharp jump from R$ 128.9 million in Q3 2025.
For investors who noticed the ticker missing from their brokerage screen: IGTI11 is a unit, which is a depositary receipt representing two common shares of the company. Some brokerages group units into a separate category from common shares, which can confuse investors searching for the paper under the "Iguatemi" name. The stock is active, trading at R$ 23.29 on November 10, 2026, with normal liquidity.
Why the R$ 438 Million Profit Requires Closer Inspection
On September 30, Iguatemi closed the sale of stakes in five properties to the real estate fund TRXF11 for R$ 876.1 million—a transaction that generated a capital gain of R$ 353.5 million, recognized entirely in the quarter. Without this gain, core adjusted profit would have been R$ 140.9 million, up 9.3% from Q3 2025. That still represents growth, but far below the headline jump. (To review the sale from the transaction angle itself, we published our complete analysis of the TRXF11 deal.)
Adjusted net revenue reached R$ 408.9 million, up 7.3% versus Q3 2025, which is a solid figure. However, looking at the underlying driver of that revenue—tenant sales within the malls—paints a more nuanced picture. Same-store sales (SSS) grew by just 0.1% compared to Q3 2025, when they had advanced 5.8%. The slowdown is sharp, and industry context makes it more visible:
Same-store sales measure revenue growth across stores operating in both compared periods, serving as the cleanest gauge of consumer momentum inside malls. While competitors such as Allos (+5.1% year-over-year) and Multiplan (+3.1% year-over-year) showed traction in Q3 2026, Iguatemi remained essentially flat. Part of the explanation lies in the portfolio shift following the recycling: the company sold stakes in five mid-income malls to TRXF11 while retaining high-income properties. Consumption in this high-end segment may have decelerated further this particular quarter, but the Q3 2026 report does not detail SSS by mall income tier, making it difficult to isolate the portfolio shift from broader macroeconomic effects.
Two indicators moved counter to weak SSS. The occupancy rate rose to 96.7%, up 0.7 percentage points versus Q3 2025, signaling that tenants still want to be in Iguatemi's malls. Meanwhile, rent per square meter on the company's proportional stake climbed 8.2%—adjustments well above inflation, demonstrating preserved pricing power despite stagnant sales. Adjusted NOI reached R$ 299 million, stable year-over-year (+0.3%), with a 95.6% margin.
The Balance Sheet Is Significantly Cleaner
The sale to TRXF11 did more than generate a capital gain; it pushed leverage down from 1.62x net debt to adjusted EBITDA in Q2 2026 to 1.04x in Q3 2026. In absolute terms, net debt fell from R$ 2.139 billion to R$ 1.749 billion, an 18.2% reduction in a single quarter. Compared to the company's 5-year historical median of 2.11x, according to site data, the balance sheet is currently in one of the strongest positions of the series. For a business whose growth model requires continuous reinvestment, this matters.
+9.3% YoY excluding the sale—what operations delivered on their own
Fell from 1.62× in Q2 2026; near recent historical lows for the company
Proportional basis; increases above inflation show pricing power
This debt reduction opens room for the new growth phase signaled by the company: a R$ 300 million investment in the Four Seasons São Paulo project, a luxury hotel developed in partnership with the international chain, with construction scheduled for 2027–2030. It is a bet on high-end hospitality, distinct from pure mall administration. To understand the deal's logic, we published how Iguatemi structured the Four Seasons São Paulo agreement.
What TRXF11's Position Means for Iguatemi Unitholders
The sale was finalized, but payment is structured in installments: a portion of the R$ 876.1 million is paid over time, adjusted by the CDI rate. This creates indirect exposure to TRXF11's financial health. If the fund runs into trouble, Iguatemi's payment schedule could stretch out. The Q3 2026 report provided no updates on the installment schedule. However, current news regarding TRXF11 is concerning: the fund announced a dividend cut after its cash reserves plummeted, directly following the capital outlay to acquire the five malls.
Iguatemi continues to manage all five properties, preserving management fee revenue and operational alignment with TRXF11. That serves as a cushion. However, the credit risk of the installment buyer is now part of the analysis for anyone holding IGTI11. XP analysts classified Q3 2026 core results as "slightly negative," with core EBITDA and FFO coming in 4% and 13% below estimates, respectively—pressure driven by weaker same-store sales and tax expenses 51% higher than expected.
Q3 2026's exceptional accounting profit will not repeat in 2027 without another asset sale. Investors evaluating IGTI11 based on reported earnings need to make adjustments: core growth is 9.3%, not 240%. The structural bright spot is leverage at 1.04x, providing room for Four Seasons capital expenditures without immediate cash strain. The immediate watchpoint is stagnant SSS: if the indicator fails to regain traction in Q4 2026—a seasonally stronger quarter due to Christmas—rental growth trends could soften in upcoming lease renewals. Our site's verdict on IGTI11 is to hold, trading at R$ 23.29 on November 10 with an estimated fair value of R$ 33.12, though the thesis depends on operations delivering what the capital gain masked.
Q4 2026 SSS — malls concentrate about 22% of annual revenue in November and December (industry estimate); an SSS recovery to 3%–4% would signal operational resumption. Two consecutive quarters below 2% would raise warnings for the rental growth thesis.
Q4 2026 Core EBITDA — without the R$ 353.5 million capital gain that distorted Q3 2026, the next quarter will show unmasked operations. The reference points are core EBITDA of R$ 309.9 million (calculated as total adjusted EBITDA of R$ 663.4 million minus the capital gain) or XP's baseline of R$ 289 million (which also excludes tax credits recognized in the quarter).
TRXF11 Installment Payments — part of the R$ 876.1 million is paid in installments adjusted by the CDI rate. Monitor Iguatemi's cash flow to confirm whether payments proceed according to the transaction schedule, especially given the buying fund's recent difficulties.
Four Seasons Capex — disbursements of R$ 300 million are scheduled for 2027–2030. As long as leverage remains below 1.5x net debt-to-EBITDA, investments should be absorbed without straining the balance sheet. Above this threshold, the margin of safety narrows and capital costs begin to weigh on valuation.
